The results of the Clopidogrel Medco Outcomes Study, [8] presented at The Society for Cardiovascular Angiography and Interventions (SCAI) meeting in May 2009, prompted the SCAI to issue a ...

Immunotherapy is offering new hope for cancers that once had grim prognoses by harnessing the body's own immune system to ...

Please provide your email address to receive an email when new articles are posted on . An intervention program was associated with an absolute reduction of 7.3% in patients who filled proton pump ...

Hypersensitivity reactions induced by proton pump inhibitors (PPIs) represent a growing concern given the extensive use of these agents for managing acid-related disorders. Although PPIs are generally ...

Explaining what PPIs are, the NHS says: "PPIs are a type of medicine which reduces the amount of acid your stomach makes.

Many people around the world either consume omeprazole or lansoprazole for their digestive problems or gut issues.However, ...

After controlling for familial factors, acid-suppressive medications in pregnancy showed no association with risk for ...

For gastric-acid reduction, the potassium-competitive acid blocker tegoprazan is associated with a lower risk of kidney function decline compared with the proton pump inhibitor esomeprazole. Use of a ...

For acute intracerebral hemorrhage, intensive blood pressure lowering was consistently linked to less neurological deterioration and better physical function without evidence of hematoma growth on CT, ...

TOKYO, Jun 2, 2025 - (JCN Newswire) - - Eisai Co., Ltd. announced today the launch of "Pariet S" (pharmaceutical requiring guidance), which is highly effective in alleviating severe heartburn ...

The NHS advises that if you take lansoprazole for more than three months, your blood magnesium levels may drop. The NHS website warns that low magnesium can lead to fatigue, confusion, dizziness, ...